{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:22Z","timestamp":1792173502628,"version":"4.4.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"44","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims\u2003<\/jats:title>\n                  <jats:p>The aim of this study was to examine contemporary data on the 1-year prognosis of patients surviving acute coronary syndrome (ACS) and concomitant first-time detected atrial fibrillation (AF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Using Danish nationwide registries, we identified all patients surviving a first-time admission with ACS from 2000 to 2018 and grouped them into (i) those without AF prior to or during ACS; (ii) those with a history of AF; and (iii) those with first-time detected AF during admission with ACS. With 1 year of follow-up, rates of ischaemic stroke, death, and bleeding were compared between study groups using multivariable adjusted Cox proportional hazards analysis. We included 161 266 ACS survivors: 135 878 (84.2%) without AF, 18 961 (11.8%) with history of AF, and 6427 (4.0%) with first-time detected AF at admission with ACS. Compared to those without AF, the adjusted 1-year rates of outcomes were as follows: ischaemic stroke [hazard ratio (HR) 1.38 (95% CI 1.22\u20131.56) for patients with history of AF and HR 1.67 (95% CI 1.38\u20132.01) for patients with first-time detected AF]; mortality [HR 1.25 (95% CI 1.21\u20131.31) for patients with history of AF and HR 1.52 (95% CI 1.43\u20131.62) for patients with first-time detected AF]; and bleeding [HR 1.22 (95% CI 1.14\u20131.30) for patients with history of AF and HR 1.28 (95% CI 1.15\u20131.43) for patients with first-time detected AF].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>In patients with ACS, first-time detected AF appeared to be at least as strongly associated with the 1-year rates of ischaemic stroke, mortality, and bleeding as compared with patients with a history of AF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab575","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T11:09:39Z","timestamp":1628939379000},"page":"4553-4561","source":"Crossref","is-referenced-by-count":41,"title":["Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1166-7877","authenticated-orcid":false,"given":"Jeppe Kofoed","family":"Petersen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-4144","authenticated-orcid":false,"given":"Jawad Haider","family":"Butt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-0080","authenticated-orcid":false,"given":"Adelina","family":"Yafasova","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-6131","authenticated-orcid":false,"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nordsj\u00e6llands Hospital , Dyrehavevej 29, Hiller\u00f8d 3400, Denmark"},{"name":"Department of Cardiology, Aalborg University Hospital , Hobrovej 18, Aalborg 9000, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-6681","authenticated-orcid":false,"given":"Rikke","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-0523","authenticated-orcid":false,"given":"Christina","family":"Kruuse","sequence":"additional","affiliation":[{"name":"Department of Neurology, Herlev Gentofte University Hospital , Borgmester Ib Juuls vej 1, Herlev 2730, Denmark"},{"name":"University of Copenhagen, Institute of Clinical Medicine , N\u00f8rre All\u00e9 20, Copenhagen 2200, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-9704","authenticated-orcid":false,"given":"Naja Emborg","family":"Vinding","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-5944","authenticated-orcid":false,"given":"Anna","family":"Gundlund","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-1466","authenticated-orcid":false,"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil Loldrup","family":"Fosb\u00f8l","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauge","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9 , Copenhagen 2100, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"2022102514451453400_ehab575-B1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/heartjnl-2015-308678","article-title":"All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome","volume":"102","author":"Batra","year":"2016","journal-title":"Heart"},{"key":"2022102514451453400_ehab575-B2","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.110.990192","article-title":"Atrial fibrillation and death after myocardial infarction: a community study","volume":"123","author":"Jabre","year":"2011","journal-title":"Circulation"},{"key":"2022102514451453400_ehab575-B3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/eurheartj\/ehi064","article-title":"Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience","volume":"26","author":"Lehto","year":"2005","journal-title":"Eur Heart J"},{"key":"2022102514451453400_ehab575-B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/europace\/euy174","article-title":"2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)","volume":"21","author":"Lip","year":"2019","journal-title":"Europace"},{"key":"2022102514451453400_ehab575-B5","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.ijcard.2013.03.037","article-title":"Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes","volume":"168","author":"Lopes","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022102514451453400_ehab575-B6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/euhj.1998.1352","article-title":"The occurrence and prognostic significance of atrial fibrillation\/-flutter following acute myocardial infarction. TRACE Study Group. TRAndolapril Cardiac Evaluation","volume":"20","author":"Pedersen","year":"1999","journal-title":"Eur Heart J"},{"key":"2022102514451453400_ehab575-B7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.101.9.969","article-title":"Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes","volume":"101","author":"Rathore","year":"2000","journal-title":"Circulation"},{"key":"2022102514451453400_ehab575-B8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur Heart J"},{"key":"2022102514451453400_ehab575-B9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2048872618769057","article-title":"Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry","volume":"8","author":"Zeymer","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022102514451453400_ehab575-B10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00392-011-0357-5","article-title":"The significance of new onset atrial fibrillation complicating acute myocardial infarction","volume":"101","author":"Zusman","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"2022102514451453400_ehab575-B11","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-021-01805-2","article-title":"Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis","author":"Fauchier","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2022102514451453400_ehab575-B12","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"2022102514451453400_ehab575-B13","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"2022102514451453400_ehab575-B14","doi-asserted-by":"crossref","first-page":"e123-55","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: an Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"2022102514451453400_ehab575-B15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"key":"2022102514451453400_ehab575-B16","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"2022102514451453400_ehab575-B17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"2022102514451453400_ehab575-B18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2022102514451453400_ehab575-B19","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102514451453400_ehab575-B20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2013.08.005","article-title":"Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy","volume":"166","author":"Fosbol","year":"2013","journal-title":"Am Heart J"},{"key":"2022102514451453400_ehab575-B21","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2018.07.054","article-title":"Combining oral anticoagulants with platelet inhibitors in patients with atrial fibrillation and coronary disease","volume":"72","author":"Sindet-Pedersen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102514451453400_ehab575-B22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"S\u00f8rensen","year":"2009","journal-title":"Lancet"},{"key":"2022102514451453400_ehab575-B23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102514451453400_ehab575-B24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022102514451453400_ehab575-B25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022102514451453400_ehab575-B26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022102514451453400_ehab575-B27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of Causes of Death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022102514451453400_ehab575-B28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ejheart.2008.05.006","article-title":"Accuracy of a heart failure diagnosis in administrative registers","volume":"10","author":"Kumler","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2022102514451453400_ehab575-B29","doi-asserted-by":"crossref","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundboll","year":"2016","journal-title":"BMJ Open"},{"key":"2022102514451453400_ehab575-B30","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"2022102514451453400_ehab575-B31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/europace\/euu225","article-title":"Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013","volume":"17","author":"Olesen","year":"2015","journal-title":"Europace"},{"key":"2022102514451453400_ehab575-B32","doi-asserted-by":"crossref","first-page":"31477","DOI":"10.1038\/srep31477","article-title":"Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: temporal trends 2011-2015 in Denmark","volume":"6","author":"Staerk","year":"2016","journal-title":"Sci Rep"},{"key":"2022102514451453400_ehab575-B33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000102143","article-title":"Validity of stroke diagnoses in a National Register of Patients","volume":"28","author":"Krarup","year":"2007","journal-title":"Neuroepidemiology"},{"key":"2022102514451453400_ehab575-B34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0895-4356(02)00391-8","article-title":"Predictive value of stroke and transient ischemic attack discharge diagnoses in the Danish National Registry of Patients","volume":"55","author":"Johnsen","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"2022102514451453400_ehab575-B35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.2109","article-title":"An automated database case definition for serious bleeding related to oral anticoagulant use","volume":"20","author":"Cunningham","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022102514451453400_ehab575-B36","volume-title":"R: A Language and Environment for Statistical Computing"},{"key":"2022102514451453400_ehab575-B37","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102514451453400_ehab575-B38","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1160\/TH16-12-0961","article-title":"Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients","volume":"117","author":"Rivera-Caravaca","year":"2017","journal-title":"Thromb Haemost"},{"key":"2022102514451453400_ehab575-B39","first-page":"899","article-title":"Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark","volume":"38","author":"Gadsb\u00f8ll","year":"2017","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/44\/4553\/46626077\/ehab575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/44\/4553\/46626077\/ehab575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T17:26:11Z","timestamp":1666718771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/44\/4553\/6363625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":39,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2021,9,3]]},"published-print":{"date-parts":[[2021,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab575","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,21]]},"published":{"date-parts":[[2021,9,3]]}}}